1. Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort
   Hoda Abel Mahedi Mohamed et al, 2018, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
2. Management of Patients under Treatment with Monoclonal Antibodies and New Biological Therapies
   Marta Amigo-Basilio et al, 2021, Applied Sciences CrossRef
3. Could MRONJ Be Related to Osimertinib Monotherapy in Lung Cancer Patients after Denosumab Suspension?
   Marta Forte et al, 2024, Healthcare CrossRef
4. Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature
   Kununya Pimolbutr et al, 2018, BioMed Research International CrossRef
5. Osteomyelitis, Osteoradionecrosis, and Medication-Related Osteonecrosis of Jaws
   Christian Walter et al, 2021, Oral and Maxillofacial Surgery for the Clinician CrossRef
6. Osteonecrosis of the jaw secondary to haematopoietic stem cell transplantation
   Shaiba Sandhu et al, 2021, BMJ Case Reports CrossRef
7. Deciphering novel chemotherapy and its impact on dentistry
   Rebecca King et al, 2020, British Dental Journal CrossRef
8. Medication-induced osteonecrosis of the jaw: a review of cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)
   Hardeep S. Ahdi et al, 2023, BMC Pharmacology and Toxicology CrossRef
9. Everolimus-induced osteonecrosis of the jaw in the absence of bisphosphonates: a case report
   S. Akkach et al, 2019, British Journal of Oral and Maxillofacial Surgery CrossRef
10. The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 2: breast cancer
    Vinod Patel et al, 2022, British Dental Journal CrossRef
11. Medication-related osteonecrosis of the jaw – a scoping review
    Nithya Jaideep Gogtay et al, 2022, Adverse Drug Reaction Bulletin CrossRef
12. Medication-Related Osteonecrosis of the Jaw Spontaneously Occurred in a Patient with Chronic Myelogenous Leukemia Only by Imatinib: A Report of a Rare Case
    Makiko Okubo-Sato et al, 2021, Case Reports in Dentistry CrossRef
13. Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab—a review
    Rebecca King et al, 2019, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
14. Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates
    L. Lorusso et al, 2021, Journal of Endocrinological Investigation CrossRef
15. The impact of sex steroids on osteonecrosis of the jaw
    Ranhee Kim et al, 2022, Osteoporosis and Sarcopenia CrossRef
16. Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: surgery or conservative therapy?
    R. Sacco et al, 2022, British Journal of Oral and Maxillofacial Surgery CrossRef
17. Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review
    null null et al, 2019, Supportive Care in Cancer CrossRef
18. Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology
    Antonio Fabrizio Nifosì et al, 2019, Journal of the Korean Association of Oral and Maxillofacial Surgeons CrossRef
19. Comorbid conditions are a risk for osteonecrosis of the jaw unrelated to antiresorptive therapy
    Kenneth E. Fleisher et al, 2019, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
20. Osteonecrosis of the jaws associated with protein kinase inhibitors: a systematic review
    Mustafa Mian et al, 2021, Oral and Maxillofacial Surgery CrossRef
21. Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset
    Antonia Marcianò et al, 2021, Journal of Clinical Medicine CrossRef